Zydus receives USFDA warning letter for Jarod facility
Earlier, on July 18, the facility received an OAI status
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Ministry of Science and Technology releases new BioE3 policy
The policy is aimed at ‘Fostering High-Performance Biomanufacturing’ aligned with National initiatives of the government of India…
Akums appoints Amrut Medhekar as CDMO CEO
He brings over 27 years of experience in the pharma industry. His expertise spans corporate strategy, business leadership, key…
Future-proofing pharma manufacturing: How companies and associations are upskilling to meet new…
Sumit Kumar, Chief Strategy Officer, TeamLease Degree Apprenticeship, highlights the importance of embracing apprenticeships,…
CDSCO reports low failure rate in cough syrup testing amid enhanced supply chain monitoring
Over 8,000 batches tested since July 2023, with only 2-3% failure rate; CDSCO strengthens regulatory measures ahead of winter…
Zydus Lifesciences receives U.S. FDA approval for Scopolamine Transdermal System
Zydus gains final approval to market Scopolamine Transdermal System, marking its fifth ANDA approval in the transdermal portfolio…
US FDA approves Emergent’s smallpox vaccine for people at high risk of mpox
FDA approves Emergent's ACAM2000 smallpox vaccine for high-risk mpox patients, amid ongoing global health concerns and recent…
COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData
COPD diagnosed prevalent cases in 7MM set to increase, with significant age and regional variations, according to GlobalData
Abaloparatide approval to enhance osteoporosis treatment landscape for high-risk patients in UK:…
NICE approves abaloparatide for high-risk osteoporosis patients in the UK, expanding treatment options and reflecting a shift…
U.S. FDA issues EIR with VAI classification for Torrent Pharmaceuticals’ Indrad facility
Torrent Pharmaceuticals Indrad manufacturing facility receives closure notice from U.S. FDA following inspection
Lupin launches Doxorubicin Hydrochloride Liposome Injection in the United States
Lupin expands oncology portfolio with the launch of a generic version of Doxil in the U.S.
IASP World Congress highlights need for unified guidelines on opioid use in chronic pain: GlobalData
Discrepancies in clinical practice guidelines prompt call for unified standards to address opioid overprescription and OUD risk
Indian Immunologicals Limited partners with ICAR-CIBA for development of fish vaccine
IIL partners with Central Institute of Brackishwater Aquaculture (CIBA), an Indian Council of Agricultural Research Institute for…
Neurocrine’s drug cuts schizophrenia symptoms in mid-stage study
The Neurocrine drug belongs to a new class of treatments that target proteins called muscarinic receptors in the central nervous…
ACG Inspection awarded GS1 Nigeria certification as solution provider
ACG inspection accredited to support compliance with NAFDAC regulations ahead of December 2024 deadline
Biocon Biologics finalises agreement for Bmab 1200 market entry in Europe, UK, Canada, and Japan
Patent dispute settlement with Janssen clears path for biosimilar to Stelara in key global markets
Avesthagen and Apollo AyurVAID partner to develop medical foods and dietary supplements
Avesthagen and Apollo AyurVAID collaborate to create scientifically validated medical foods and dietary supplements integrating…
rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks:…
Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks
Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution
Lupin to market generic version of AbbVie's Alphagan P for elevated intraocular pressure, manufactured at its Pithampur facility
Bharat Biotech launches oral cholera vaccine HILLCHOL to address global shortage
New manufacturing facilities aim to bridge critical vaccine supply gap